Cassady Schiller Wealth Management’s Elevance Health ELV Stock Holding History

Cassady Schiller Wealth Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$229K	Buy	622 +15	+2%	+$6.28K	0.08%	110
2024 Q3	$316K	Hold	607	–	–	0.12%	89
2024 Q2	$329K	Sell	607 -50	-8%	-$26.4K	0.13%	83
2024 Q1	$341K	Buy	657 +6	+0.9%	+$2.98K	0.15%	80
2023 Q4	$307K	Sell	651 -265	-29%	-$123K	0.15%	77
2023 Q3	$399K	Hold	916	–	–	0.22%	68
2023 Q2	$407K	Hold	916	–	–	0.22%	70
2023 Q1	$421K	Hold	916	–	–	0.2%	66
2022 Q4	$470K	Sell	916 -72	-7%	-$36.6K	0.29%	59
2022 Q3	$449K	Hold	988	–	–	0.26%	61
2022 Q2	$477K	Hold	988	–	–	0.25%	58
2022 Q1	$485K	Buy	988 +13	+1%	+$5.94K	0.23%	63
2021 Q4	$452K	Buy	+975	New	+$410K	0.27%	57

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cassady Schiller Wealth Management's ELV Position: Q4 2024 in Review

Cassady Schiller Wealth Management increased its Elevance Health (ELV) stake by 2.5% in Q4 2024, buying an estimated $6.28K and bringing the position to 622 shares worth $229K. The position accounts for 0.08% of the portfolio, ranked #110.

Cassady Schiller Wealth Management first reported a position in ELV in Q4 2021 and has held it in 13 quarters since. The position peaked at $485K in Q1 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

Cassady Schiller Wealth Management held 622 shares of Elevance Health worth $229K as of Q4 2024.
Cassady Schiller Wealth Management bought 15 Elevance Health shares in Q4 2024, an estimated $6.28K.
Elevance Health made up 0.08% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #110 holding.
Cassady Schiller Wealth Management first reported a position in Elevance Health in Q4 2021 and has held it in 13 quarters since.
Cassady Schiller Wealth Management's Elevance Health position peaked at $485K in Q1 2022.
1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.